| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Department of Surgery, University of Washington, Seattle.
Correspondence to Günter Daum, PhD, Department of Surgery, Box 356410, University of Washington, 1959 NE Pacific St, Seattle, WA 98195-6410. E-mail daum{at}u.washington.edu
Objective Intimal growth depends on smooth muscle cell (SMC) migration and proliferation and is regulated by thrombotic and inflammatory responses to vascular injury. Platelet-derived growth factor (PDGF)-BB and interleukin (IL)-1ß have been shown to contribute to intimal hyperplasia and lesion progression in atherosclerosis. Mitogenic effects of IL-1 on SMCs have been reported and have been attributed to the expression of PDGF-A chain. In some, but not all, studies, IL-1ß was found to cooperate with growth factors, including PDGF, in stimulating proliferation. The molecular basis for such cooperative effects is unknown and is the subject of the present study.
Methods and Results We demonstrate that in baboon aortic SMCs, IL-1ß enhances the proliferation induced by PDGF-BB independently of PDGF-A signaling. IL-1ß increases the phosphorylation of retinoblastoma protein, a pivotal step in the G1-to-S transition in the cell cycle. Analysis of expression levels of cyclins and cyclin-dependent kinase (CDK) inhibitors suggests that IL-1ß stimulates CDKs by downregulating p21 and p27. Consistent with this hypothesis is the finding that CDK2 activity, induced by PDGF-BB, is enhanced 2.3±0.2-fold in the presence of IL-1ß.
Conclusions Our data suggest that IL-1ß may promote SMC proliferation after vascular injury and in atherogenesis by suppression of PDGF-BBinduced p21 and p27.
Key Words: smooth muscle platelet-derived growth factor interleukin-1 p21(WAF1/CIP1) p27(KIP1)
This article has been cited by other articles:
![]() |
Y. Hou, K. Okada, C. Okamoto, S. Ueshima, and O. Matsuo Alpha2-Antiplasmin Is a Critical Regulator of Angiotensin II-Mediated Vascular Remodeling Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1257 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhu, Y. Lin, M. Bacanamwo, L. Chang, R. Chai, I. Massud, J. Zhang, M. T. Garcia-Barrio, W. E. Thompson, and Y. E. Chen Interleukin-1 {beta}-induced Id2 gene expression is mediated by Egr-1 in vascular smooth muscle cells Cardiovasc Res, October 1, 2007; 76(1): 141 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Nestor, G. T. Cicila, S. E. Karol, K. M. Langenderfer, S. L. Hollopeter, and D. C. Allison Linkage analysis of neointimal hyperplasia and vascular wall transformation after balloon angioplasty Physiol Genomics, April 13, 2006; 25(2): 286 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mukhopadhyay, M. A. Ali, A. Nandi, P. Carreon, H. Choy, and D. Saha The Cyclin-Dependent Kinase 2 Inhibitor Down-regulates Interleukin-1{beta}-Mediated Induction of Cyclooxygenase-2 Expression in Human Lung Carcinoma Cells Cancer Res., February 1, 2006; 66(3): 1758 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yu, D. A. Quinn, H. G. Garg, and C. A. Hales Cyclin-Dependent Kinase Inhibitor p27Kip1, But Not p21WAF1/Cip1, Is Required for Inhibition of Hypoxia-Induced Pulmonary Hypertension and Remodeling by Heparin in Mice Circ. Res., October 28, 2005; 97(9): 937 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Qureshi, H. Chen, A. T Brown, R. Fitzgerald, X. Zhang, J. Breckenridge, R. Kazi, A. J Crocker, M. C Stuhlingexsr, K. Lin, et al. Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor Vascular Medicine, August 1, 2005; 10(3): 215 - 223. [Abstract] [PDF] |
||||
![]() |
R. ZIESCHE, V. PETKOV, C. LAMBERS, P. ERNE, and L.-H. BLOCK The calcium channel blocker amlodipine exerts its anti-proliferative action via p21(Waf1/Cip1) gene activation FASEB J, October 1, 2004; 18(13): 1516 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Andres Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential Cardiovasc Res, July 1, 2004; 63(1): 11 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
G Troncone, A Iaccarino, A Caleo, D Bifano, G Pettinato, and L Palombini p27Kip1 protein expression in Hashimoto's thyroiditis J. Clin. Pathol., August 1, 2003; 56(8): 587 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kirii, T. Niwa, Y. Yamada, H. Wada, K. Saito, Y. Iwakura, M. Asano, H. Moriwaki, and M. Seishima Lack of Interleukin-1{beta} Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 656 - 660. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |